The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Internationalization Strategies of Chinese Pharmaceutical Firms
Abstract
China’s pharmaceutical market value is about USD 110 billion in 2009, and it has become the world’s second largest market. Chinese pharmaceutical firms are becoming a growing player in the global pharmaceutical chain. Through empirical research, this chapter summarizes the internationalization experience of Chinese pharmaceutical firms, finds that the effective strategies of international market entry are product upgrading along the industrial chain, international certification and cooperation, outsourcing and licensing, and other paths of overseas expansion, and presents that pharmaceutical firms in emerging markets should choose suitable entry paths and strategies according to their own advantages, learn the experience of internationalization from leading firms in emerging market, and gradually enter the standard market.
Related Content
|
Alice S. Etim, Wole Michael Olatokun.
© 2024.
20 pages.
|
|
Lilian C. Mutalemwa.
© 2024.
27 pages.
|
|
G. Nixon Samuel Vijayakumar, Vinay Kumar Domakonda, Shaik Farooq, B. Senthil Kumar, N. Pradeep, Sampath Boopathi.
© 2024.
34 pages.
|
|
Elisha Mupaikwa, Kelvib Joseph Bwalya.
© 2024.
35 pages.
|
|
Oluwatoyin Catherine Agbonifo, Samuel Ibukun Olotu, Toyosi Ayo Oluwatusin.
© 2024.
22 pages.
|
|
James S. Etim.
© 2024.
19 pages.
|
|
Vanessa Hiu Ying Chan, Dickson K. W. Chiu.
© 2024.
24 pages.
|
|
|